X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45618) 45618
Newspaper Article (266) 266
Newsletter (226) 226
Book Chapter (75) 75
Dissertation (34) 34
Magazine Article (28) 28
Publication (16) 16
Book / eBook (11) 11
Conference Proceeding (11) 11
Book Review (5) 5
Government Document (4) 4
Reference (4) 4
Trade Publication Article (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (33696) 33696
male (24501) 24501
rats (21800) 21800
neurosciences (17798) 17798
dopamine (17773) 17773
pharmacology & pharmacy (14201) 14201
humans (10375) 10375
dopamine - metabolism (8691) 8691
rats, sprague-dawley (7891) 7891
female (7272) 7272
mice (7148) 7148
dose-response relationship, drug (7050) 7050
psychiatry (6692) 6692
dopamine antagonists - pharmacology (5521) 5521
brain (5006) 5006
rats, wistar (4544) 4544
nucleus-accumbens (4414) 4414
motor activity - drug effects (4314) 4314
neurons (3968) 3968
schizophrenia (3909) 3909
rat (3827) 3827
cocaine (3696) 3696
receptors (3689) 3689
behavior, animal - drug effects (3603) 3603
dopamine - pharmacology (3383) 3383
dopamine agonists - pharmacology (3352) 3352
corpus striatum - metabolism (3344) 3344
dopamine - physiology (3209) 3209
serotonin (3126) 3126
time factors (3122) 3122
benzazepines - pharmacology (3076) 3076
ventral tegmental area (3056) 3056
in vitro techniques (3055) 3055
haloperidol - pharmacology (3028) 3028
neurons - drug effects (3021) 3021
corpus striatum - drug effects (3011) 3011
brain - metabolism (2949) 2949
rats, inbred strains (2937) 2937
biochemistry & molecular biology (2926) 2926
receptors, dopamine - drug effects (2815) 2815
brain - drug effects (2804) 2804
dopamine receptors (2750) 2750
prefrontal cortex (2638) 2638
rodents (2611) 2611
striatum (2576) 2576
adult (2529) 2529
dopamine antagonists (2472) 2472
reward (2440) 2440
amphetamine (2388) 2388
microdialysis (2342) 2342
clinical neurology (2327) 2327
receptors, dopamine d2 - metabolism (2326) 2326
nucleus accumbens - drug effects (2308) 2308
nucleus accumbens (2305) 2305
parkinson's disease (2289) 2289
drug interactions (2260) 2260
antipsychotic agents - pharmacology (2231) 2231
disease models, animal (2217) 2217
haloperidol (2215) 2215
neurology (2194) 2194
dopamine release (2180) 2180
pharmacology (2177) 2177
cocaine - pharmacology (2168) 2168
behavioral sciences (2132) 2132
glutamate (2090) 2090
phenols (2083) 2083
research (2064) 2064
biomedicine (2061) 2061
parkinsons-disease (2058) 2058
receptor (2047) 2047
neurons - metabolism (2030) 2030
release (1991) 1991
mice, inbred c57bl (1967) 1967
apomorphine - pharmacology (1958) 1958
analysis (1940) 1940
rat-brain (1924) 1924
analysis of variance (1872) 1872
in-vivo (1852) 1852
behavior (1845) 1845
dopamine agents - pharmacology (1843) 1843
basal ganglia (1820) 1820
dopamine d2 receptor antagonists (1792) 1792
pharmacology/toxicology (1785) 1785
expression (1780) 1780
nucleus accumbens - metabolism (1766) 1766
nervous system (1733) 1733
dopamine uptake inhibitors - pharmacology (1709) 1709
reinforcement (1693) 1693
serotonin - metabolism (1646) 1646
physiological aspects (1599) 1599
activation (1589) 1589
receptors, dopamine - metabolism (1584) 1584
excitatory amino acid antagonists - pharmacology (1574) 1574
inhibition (1571) 1571
drugs (1561) 1561
norepinephrine - metabolism (1512) 1512
neurons - physiology (1492) 1492
sulpiride - pharmacology (1473) 1473
addiction (1455) 1455
physiology (1449) 1449
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (45716) 45716
Japanese (390) 390
Russian (209) 209
French (102) 102
German (98) 98
Chinese (55) 55
Spanish (32) 32
Italian (26) 26
Polish (14) 14
Turkish (6) 6
Ukrainian (6) 6
Dutch (5) 5
Bulgarian (4) 4
Portuguese (4) 4
Finnish (3) 3
Hungarian (3) 3
Romanian (3) 3
Danish (2) 2
Arabic (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 1/2014, Volume 231, Issue 1, pp. 269 - 281
... deficits.We evaluated the effects of the combined administration of the 5-HT6 receptor antagonist SB 271046 with clozapine and haloperidol, as well as the co-administration of SB 271046 or SB 399885... 
Antipsychotics | Neurosciences | 5-HT2A receptor | Biomedicine | 5-HT6 receptor | Startle response | Schizophrenia | Clozapine | Pharmacology/Toxicology | Risperidone | Psychiatry | Prepulse inhibition | HALOPERIDOL | PSYCHIATRY | NEUROSCIENCES | PHENCYCLIDINE | DISRUPTION | SERTINDOLE | MEDIAL PREFRONTAL CORTEX | ANIMAL-MODELS | INDUCED DEFICITS | DIZOCILPINE | PHARMACOLOGY & PHARMACY | Data Interpretation, Statistical | Receptors, Serotonin - drug effects | Risperidone - pharmacology | Rats | Thiophenes - pharmacology | Male | Excitatory Amino Acid Antagonists - pharmacology | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Serotonin Antagonists - pharmacology | Sulfonamides - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Clozapine - pharmacology | Animals | Drug Interactions | Piperidines - pharmacology | Dopamine Antagonists - pharmacology | Reflex, Startle - drug effects | Antipsychotic Agents - pharmacology | Dizocilpine Maleate - pharmacology | Haloperidol - pharmacology | Complications and side effects | Antipsychotic drugs | Dosage and administration | Haloperidol | Research | Drug therapy | Psychotropic drugs | Inhibitor drugs | Psychopharmacology | Antagonists | Original Investigation
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 1740-634X, 2008, Volume 34, Issue 3, pp. 681 - 697
Psychopharmacological studies have implicated the mesolimbic dopamine (DA) system in the mediation of cost/benefit evaluations about delay or effort-related... 
Discounting | Gambling | Amphetamine | Parkinson's disease | receptors | D-1 RECEPTOR | PSYCHIATRY | discounting | amphetamine | gambling | NEUROCHEMICAL PROFILE | NORMAL VOLUNTEERS | NEUROSCIENCES | VENTROMEDIAL PREFRONTAL CORTEX | D-2 receptors | IMPULSIVE BEHAVIOR | D-3 receptors | PHARMACOLOGY & PHARMACY | RECEPTOR GENE | D-AMPHETAMINE | PROBABILISTIC REINFORCEMENT | WORKING-MEMORY | PARKINSONS-DISEASE | Receptors, Dopamine D4 - agonists | Rats, Long-Evans | Decision Making - drug effects | Risk | Receptors, Dopamine D4 - antagonists & inhibitors | Pyrrolidines - pharmacology | Conditioning, Operant - drug effects | Receptors, Dopamine D1 - agonists | Behavior, Animal - drug effects | Benzamides - pharmacology | Benzopyrans - pharmacology | Receptors, Dopamine D3 - antagonists & inhibitors | Oxazines - pharmacology | Receptors, Dopamine D1 - antagonists & inhibitors | Dopamine Agonists - pharmacology | Dextroamphetamine - pharmacology | Receptors, Dopamine D2 - agonists | Rats | Behavior, Animal - physiology | Bromocriptine - pharmacology | Benzazepines - pharmacology | Piperazines - pharmacology | Naphthalenes - pharmacology | Receptors, Dopamine D3 - agonists | Reinforcement Schedule | Pyrroles - pharmacology | Animals | Dopamine Antagonists - pharmacology | Decision Making - physiology | Pyridines - pharmacology | Dopamine D2 Receptor Antagonists | Salicylamides - pharmacology
Journal Article
Cell, ISSN 0092-8674, 06/2012, Volume 149, Issue 6, pp. 1284 - 1297
Journal Article
PLoS neglected tropical diseases, ISSN 1935-2735, 2019, Volume 13, Issue 8, p. e0007573
...) receptor antagonists, as well as a dopamine reuptake inhibitor (BTCP). Neuropeptides, FMRFamide, peptide YY, and neuropeptide Y were also potent inhibitors of chemotaxis... 
TREMATODE | FASCIOLA-HEPATICA | TYROSINE-HYDROXYLASE | CLONING | ACETYLCHOLINE | SCHISTOSOMA-MANSONI | DOPAMINE | RECEPTOR | SEROTONIN | PARASITOLOGY | TROPICAL MEDICINE | MOTILITY | Peptide YY - pharmacology | Sulpiride - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Dopamine - pharmacology | Fluorenes - pharmacology | Neuropeptide Y - pharmacology | Chemotaxis - drug effects | Clonorchis sinensis - drug effects | Piperazines - pharmacology | Fasciola hepatica - drug effects | Animals | Chemotaxis - physiology | Serotonin Agents - pharmacology | Biphenyl Compounds - pharmacology | Neurotransmitter Agents - pharmacology | Excitatory Amino Acid Agents - pharmacology | Clonorchis sinensis - physiology | Benzamides - pharmacology | Cholic Acid | FMRFamide - pharmacology | Spiro Compounds - pharmacology | Neurosciences | Motility | Peptides | Leukocyte migration | Nervous system | Neuropeptides | Biology | Parasites | Cholic acid | Juveniles | Sulpiride | Neuromodulation | Modulators | FMRFamide | Proteins | Receptors | Dopamine D2 receptors | Minors | University colleges | Neuropeptide Y | Parasitology | Dopamine | Serotonin | Duodenum | Neurons | Fluoxetine | Immunomodulation | Cloning | Dopamine D3 receptors | Muscles | Chemotaxis | Bile duct | Cholinergics | Medicine | Inhibitors | Dopamine D1 receptors | Acids | Glutamatergic transmission | Laboratory animals | Immunofluorescence | Cell migration | Bile
Journal Article
Schizophrenia bulletin, ISSN 1745-1701, 2012, Volume 38, Issue 5, pp. 942 - 949
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2018, Volume 43, Issue 2, pp. 313 - 324
..., USA; 5Departments of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD, USA; 6Departments of Physiology, School of Medicine, University... 
IOWA GAMBLING TASK | PSYCHIATRY | BASOLATERAL AMYGDALA | BIPOLAR DISORDER | NEUROSCIENCES | RECEPTOR ANTAGONIST | PREFRONTAL CORTEX | CORTICOTROPIN-RELEASING-FACTOR | ANIMAL-MODELS | PHARMACOLOGY & PHARMACY | SUICIDAL-BEHAVIOR | ORBITOFRONTAL CORTEX | GENDER-DIFFERENCES | Receptors, Corticotropin-Releasing Hormone - metabolism | Rats, Long-Evans | Decision Making - drug effects | Male | Receptors, Dopamine D2 - metabolism | Yohimbine - pharmacology | Behavior, Animal - drug effects | Female | Adrenergic alpha-2 Receptor Antagonists - administration & dosage | Dopamine Agonists - pharmacology | Receptors, Dopamine D2 - agonists | Amygdala - metabolism | Rats | Behavior, Animal - physiology | Pyrimidines - pharmacology | Sex Characteristics | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Pyrroles - pharmacology | Animals | Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors | Dopamine Agonists - administration & dosage | Dopamine D2 Receptor Antagonists - administration & dosage | Dopamine D2 Receptor Antagonists - pharmacology | Decision Making - physiology | Quinpirole - pharmacology | Salicylamides - pharmacology | Gambling | Amygdala | Yohimbine | Mental disorders | Disorders | Sex | mRNA | Estrus cycle | Gender | Males | Rodents | Gender aspects | Dopamine D2 receptors | Stresses | Estrus | Dopamine | Decision making | Antalarmin | Sex differences | Gender differences | Pharmacology | Corticotropin-releasing hormone | Stress | Quinpirole | Animal behavior | Adrenergic receptors | Females | Original
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 134, Issue 7, pp. 2004 - 2013
...), 5-HT agonists, and vagotomy as well as the decrease-suppressing effects of rikkunshito and 5-HT antagonists... 
Gastroenterology and Hepatology | SEROTONIN RECEPTOR | GHRELIN LEVELS | SYMPTOMS | MICE | EMESIS | GASTROENTEROLOGY & HEPATOLOGY | STOMACH | Receptor, Serotonin, 5-HT2B - metabolism | Receptor, Serotonin, 5-HT2C - metabolism | Body Weight - drug effects | Drugs, Chinese Herbal - pharmacology | Male | Stomach - metabolism | Drugs, Chinese Herbal - metabolism | Anorexia - physiopathology | Quinolines - pharmacology | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Serotonin 5-HT2 Receptor Antagonists | Chalcones - pharmacology | Dopamine Antagonists - metabolism | Receptors, Ghrelin - metabolism | Indoles - pharmacology | Stomach - innervation | Stomach - drug effects | Drugs, Chinese Herbal - therapeutic use | Flavones - pharmacology | Acylation | Disease Models, Animal | Antineoplastic Agents | Rats | Thiophenes - pharmacology | Anorexia - metabolism | Dopamine Antagonists - therapeutic use | Receptors, Ghrelin - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Vagotomy | Cisplatin | Ghrelin - metabolism | Eating - drug effects | Gastrointestinal Agents - pharmacology | Ghrelin - blood | Animals | Dopamine Antagonists - pharmacology | Aminopyridines - pharmacology | Serotonin - metabolism | Gastrointestinal Agents - therapeutic use | Anorexia - prevention & control | Hesperidin - pharmacology | Protein Binding | Anorexia - chemically induced | Oligopeptides - pharmacology | Gastrointestinal Agents - metabolism | Medicine, Botanic | Medicine, Herbal
Journal Article
Molecular psychiatry, ISSN 1476-5578, 2013, Volume 19, Issue 10, pp. 1106 - 1114
.... We show that selective serotonin 2C (5-HT2C) antagonists exert antidepressant actions with a faster-onset (5 days... 
Antidepressant | mTOR | BDNF | Neuronal remodeling | eEF | PATHWAYS | DEPRESSION | PSYCHIATRY | NEUROTROPHIC FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | antidepressant | INCREASES | neuronal remodeling | CHRONIC MILD STRESS | ELEMENT-BINDING PROTEIN | NEUROSCIENCES | CHRONIC FLUOXETINE | 5-HT2C RECEPTOR | ANIMAL-MODELS | OLFACTORY BULBECTOMIZED RATS | Citalopram - pharmacology | TOR Serine-Threonine Kinases - metabolism | Depressive Disorder - pathology | Prefrontal Cortex - physiopathology | Receptor, Serotonin, 5-HT2C - metabolism | Elongation Factor 2 Kinase - metabolism | Depressive Disorder - drug therapy | Prefrontal Cortex - pathology | Receptors, Dopamine D1 - metabolism | Prefrontal Cortex - drug effects | Time Factors | Female | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Pyramidal Cells - drug effects | Disease Models, Animal | Receptors, Dopamine D1 - antagonists & inhibitors | Olfactory Bulb - physiopathology | Pyramidal Cells - physiopathology | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Animals | Depressive Disorder - physiopathology | Cyclic AMP Response Element-Binding Protein - metabolism | Pyramidal Cells - pathology | Stress, Psychological | Mice, Inbred BALB C | Serotonin Uptake Inhibitors - pharmacology | Chronic Disease | Antagonists (Biochemistry) | Usage | Serotonin | Antidepressants | Depression, Mental | Patient outcomes | Physiological aspects | Research | Drug therapy | Health aspects
Journal Article